Reproductive BioMedicine Online
Volume 19, Issue 6 , Pages 784-788 , December 2009

Effect of vascular endothelial growth factor on sperm motility and survival

  • Ahmet Cem Iyibozkurt

      Affiliations

    • Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
    • Corresponding Author InformationCorrespondence:
  • ,
  • Pelin Balcik

      Affiliations

    • Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • ,
  • Sibel Bulgurcuoglu

      Affiliations

    • Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • ,
  • Burcu Kardaş Arslan

      Affiliations

    • Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
  • ,
  • Rükset Attar

      Affiliations

    • Department of Obstetrics and Gynecology, Yeditepe Medical Faculty, Yeditepe University, Istanbul, Turkey
  • ,
  • Erkut Attar

      Affiliations

    • Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Received 19 August 2008 ,Revised 20 February 2009 ,Accepted 24 June 2009.

References 

  1. Attar E, Ozsait B, Bulgurcuoglu S, et al. Effect of leukaemia inhibitory factor on long-term sperm motility and survival. Reproductive BioMedicine Online. 2003;7:71–74
  2. Brown LF, Yeo KT, Berse B, et al. Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. The Journal of Urology. 1995;154:576–579
  3. Chong ZZ, Maiese K. Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histology and Histopathology. 2004;19:495–504
  4. Ebisch IM, Thomas CM, Wetzels AM, et al. Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility. Fertility and Sterility. 2008;90:2340–2350
  5. Ergun S, Kilic N, Fiedler W, et al. Vascular endothelial growth factor and its receptors in normal human testicular tissue. Molecular and Cellular Endocrinology. 1997;131:9–20
  6. Fasciani A, D’Ambrogio G, Bocci G, et al. High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Molecular Human Reproduction. 2000;6:50–54
  7. Gallon F, Marchetti C, Jouy N, et al. The functionality of mitochondria differentiates human spermatozoa with high and low fertilizing capability. Fertility and Sterility. 2006;86:1526–1530
  8. Gawlik V, Schmidt S, Scheepers A, et al. Targeted disruption of Slc2a8 (GLUT 8) reduces motility and mitochondrial potential of spermatozoa. Molecular Membrane Biology. 2008;25:224–235
  9. Gordon JD, Mesiano S, Zaloudek CJ, et al. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. The Journal of Clinical Endocrinology and Metabolism. 1996;81:353–359
  10. Ho QT, Kuo CJ. Vascular endothelial growth factor: biology and therapeutic applications. The International Journal of Biochemistry and Cell Biology. 2007;39:1349–1357
  11. Huminiecki L, Chan HY, Lui S, et al. Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection. Molecular Human Reproduction. 2001;7:255–264
  12. Jeyendran RS, Van derVen HH, Perez-Pelaez M, et al. Development of an assay to assess the functional integrity of the human sperm membrane and its relationship to other semen characteristics. Journal of Reproduction and Fertility. 1984;70:219–228
  13. Kasai T, Ogawa K, Mizuno K, et al. Relationship between sperm mitochondrial membrane potential, sperm motility, and fertility potential. Asian Journal of Andrology. 2002;4:97–103
  14. Keltz MD, Attar E, Buradagunta S, et al. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in the human fallopian tube. American Journal of Obstetrics and Gynecology. 1996;175:1611–1619
  15. Korpelainen EI, Karkkainen MJ, Tenhunen A, et al. Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. The Journal of Cell Biology. 1998;143:1705–1712
  16. Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:15809–15814
  17. Nalbandian A, Dettin L, Dym M, et al. Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse. Biology of Reproduction. 2003;69:985–994
  18. Navarro J, Garrido N, Remohi J, et al. How does endometriosis affect infertility?. Obstetrics and Gynecology Clinics of North America. 2003;30:181–192
  19. Obermair A, Obruca A, Pohl M, et al. Vascular endothelial growth factor and its receptors in male fertility. Fertility and Sterility. 1999;72:269–275
  20. Schmidt JA, de Avila JM, McLean DJ. Effect of vascular endothelial growth factor and testis tissue culture on spermatogenesis in bovine ectopic testis tissue xenografts. Biology of Reproduction. 2006;75:167–175
  21. Sun ZM, Ding CF, Yan ZZ, et al. Ultrastructure and function of mitochondria in idiopathic asthenospermia: study of 151 cases. Zhonghua Yi Xue Za Zhi. 2007;87:1263–1265
  22. von Wolff M, Nowak O, Pinheiro RM, et al. Seminal plasma – immunomodulatory potential in men with normal and abnormal sperm count. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2007;134:73–78
  23. Wang JA, Chen TL, Jiang J, et al. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacologica Sinica. 2008;29:74–82
  24. World Health Organization 1999 WHO Laboratory Manual for the Examination of Human Semen and Sperm–Cervical Mucus Interaction. Cambridge University Press, Cambridge, UK, p. 106.
  25. Wright GL, Maroulakou IG, Eldridge J, et al. VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology. 2008;22:3264–3275

 Dr A Cem Iyibozkurt is currently working as a specialist and a fellow in the Department of Obstetrics and Gynecology, Istanbul Faculty of Medicine, Istanbul University, Turkey. After qualifying as MD at Cerrahpasa Medical School, Istanbul University he completed his Obstetrics and Gynecology residency at Istanbul University in 2004. His thesis was on the comparative effect of selective COX-2 blockers and aspirin on three-dimensional cell cultures from endometriosis, endometrium and endometrial cancer. His special interests are gynaecologic cancer, endometriosis and cell cultures. Dr A Cem Iyibozkurt

PII: S1472-6483(09)00083-2

doi: 10.1016/j.rbmo.2009.09.019

Reproductive BioMedicine Online
Volume 19, Issue 6 , Pages 784-788 , December 2009